Category: Investor updates

Imagion Biosystems has announced the successful completion of the renounceable rights issue raising approximately $3.6 million. Read Imagion Biosystems’ Right Issue raises $3.6 million.

Imagion Biosystems Limited (ASX: IBX) (the Company) refers to its renounceable pro rata right issue offer of new fully paid ordinary shares (New Shares) announced

Imagion Biosystems Limited has announced a supplementary prospectus (Supplementary Prospectus) which shall be read with the prospectus dated 28 October 2019 (Prospectus) and issued by

Imagion Biosystems Limited (ASX: IBX) (the Company), is pleased to confirm that the rights associated with the Company’s Renounceable Rights Issue announced on 28 October

Imagion Biosystems has released its Quarterly Cashflow Report for the period ending 30 September 2019. Read Appendix 4C.

Imagion Biosystems has announced a notification to ineligible shareholders regarding the renounceable pro-rata offer of 28 October 2019. Read the notification.

Imagion Biosystems has announced a letter to shareholders regarding the 28 October 2019 announcement of a renounceable pro-rata offer. Read the letter to shareholders.

Imagion Biosystems announces an amendment to the previously announced close date. For the purposes of the Pro-Rata Renewable Rights Issue, the indicative close date is

Imagion Biosystems has announced and amendment to the proposed timetable for the Pro-Rata Renounceable Rights Issue as announced on Monday, 28 October 2019. Read the